Annoglabasin B

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H34O4
Molecular Weight	362.503
Optical Activity	( - )
Defined Stereocenters	7 / 7
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=O)OC[C@]1(C)CCC[C@@]2(C)[C@@H]3CC[C@@H]4C[C@]3(C[C@@H]4C(O)=O)CC[C@H]12

InChI

InChIKey=ZKXLEDOCSSUHKY-BJWFUVPOSA-N

InChI=1S/C22H34O4/c1-14(23)26-13-20(2)8-4-9-21(3)17(20)7-10-22-11-15(5-6-18(21)22)16(12-22)19(24)25/h15-18H,4-13H2,1-3H3,(H,24,25)/t15-,16+,17-,18+,20+,21-,22+/m1/s1

HIDE SMILES / InChI

Molecular Formula	C22H34O4
Molecular Weight	362.503
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	7 / 7
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 08:03:18 GMT 2025` Edited by `admin` on `Wed Apr 02 08:03:18 GMT 2025`
Record UNII	7ZXC35EQF6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Annoglabasin B

Common Name

English

(4?)-18-(Acetyloxy)kauran-17-oic acid

Preferred Name

English

Kauran-17-oic acid, 18-(acetyloxy)-, (4?)-

Common Name

English

(1S,4S,5R,9S,10R,13R,14S)-5-(acetyloxymethyl)-5,9-dimethyltetracyclo[11.2.1.01,10.04,9]hexadecane-14-carboxylic acid

Systematic Name

English

Code System Code Type Description

FDA UNII

7ZXC35EQF6

Created by admin on Wed Apr 02 08:03:18 GMT 2025 , Edited by admin on Wed Apr 02 08:03:18 GMT 2025

PRIMARY

CAS

205312-86-3

Created by admin on Wed Apr 02 08:03:18 GMT 2025 , Edited by admin on Wed Apr 02 08:03:18 GMT 2025

PRIMARY

EPA CompTox

DTXSID701286014

Created by admin on Wed Apr 02 08:03:18 GMT 2025 , Edited by admin on Wed Apr 02 08:03:18 GMT 2025

PRIMARY

PUBCHEM

20055740

Created by admin on Wed Apr 02 08:03:18 GMT 2025 , Edited by admin on Wed Apr 02 08:03:18 GMT 2025

PRIMARY